- ►diabetesjournals.org N Ogawa, JF List, JF Habener, T Maki - Diabetes, 2004 - Am Diabetes Assoc Treatment of overtly diabetic NOD mice with anti-lymphocyte serum (ALS), a
polyclonal anti–T-cell antibody, abrogates autoimmunity and achieves partial
clinical remission. Here we investigated whether the addition of exendin-4, ... Cited by 82 - Related articles - BL Direct - All 6 versions
Z Yang, M Chen, JD Carter, CS Nunemaker, … - Biochemical and Biophysical Research …, 2006 - Elsevier Type 1 diabetes mellitus (T1DM) is an autoimmune disease leading to near
complete pancreatic β-cell destruction. New evidence suggests that β-cell
regeneration is possible, but ongoing autoimmune damage prevents ... Cited by 20 - Related articles - All 5 versions
- ►endojournals.org NA Sherry, W Chen, JA Kushner, M Glandt, Q … - Endocrinology, 2007 - Endocrine Soc Immune modulators can arrest loss of insulin secretion in type 1 diabetes
mellitus (T1DM), but they have not caused permanent disease remission or
restored normal insulin secretion. We tested whether exendin-4, a ... Cited by 25 - Related articles - BL Direct - All 5 versions
- ►alphamedpress.org TD Zorina, VM Subbotin, S Bertera, AM … - Stem Cells, 2003 - AlphaMed Press In light of accumulating evidence that the endocrine pancreas has regenerative
properties and that hematopoietic chimerism can abrogate destruction of ß cells
in autoimmune diabetes, we addressed the question of whether recovery of ... Cited by 80 - Related articles - BL Direct - All 5 versions
- ►pnas.org [PDF] T Maki, T Ichikawa, R Blanco, J Porter - Proceedings of the National Academy of Sciences, 1992 - National Acad Sciences Page 1. Proc. Nadl. Acad. Sci. USA Vol. 89, pp. 3434-3438, April 1992 Medical
Sciences Long-term abrogation of autoimmune diabetes ... Cited by 71 - Related articles - All 8 versions
I Rooman, L Bouwens - Diabetologia, 2004 - Springer Aims/hypothesis. Increasing beta-cell mass and/or function could restore glucose
homeostasis in diabetes mellitus. Hitherto, trophic factors for beta-cell regen-
eration after toxic events have been difficult to identi- fy. We evaluated ... Cited by 63 - Related articles - BL Direct - All 4 versions
TD Zorina, VM Subbotin, S Bertera, AM … - Cell Transplantation, 2002 - ingentaconnect.com Printed in the USA. All rights reserved. ... Copyright 2002 Cognizant Comm.
Corp. www.cognizantcommunication.com ... Distinct Characteristics and Features
of Allogeneic Chimerism ... Tatiana D. Zorina,* Vladimir M. Subbotin,† ... Cited by 20 - Related articles - BL Direct - All 2 versions
- ►nih.gov M Trucco - Journal of Clinical Investigation, 2005 - Am Soc Clin Investig Type 1 diabetes is the result of an autoimmune attack against the
insulin-producing β cells of the endocrine pancreas. Current treatment for
patients with type 1 diabetes typically involves a rigorous and invasive ... Cited by 69 - Related articles - All 9 versions
- ►endojournals.org I Hadjiyanni, LL Baggio, P Poussier, DJ … - Endocrinology, 2008 - Endocrine Soc Activation of the glucagon-like peptide-1 receptor (GLP-1R) is associated with
expansion of β-cell mass due to stimulation of cell proliferation and induction
of antiapoptotic pathways coupled to β-cell survival. Although the GLP-1R ... Cited by 11 - Related articles - BL Direct - All 5 versions
J Zhang, Y Tokui, K Yamagata, J Kozawa, K … - Diabetologia, 2007 - Springer Page 1. ARTICLE Continuous stimulation of human glucagon-like peptide-1 (7–36) amide
in a mouse model (NOD) delays onset of autoimmune type 1 diabetes ... Cited by 12 - Related articles - All 5 versions
